INSERM - Institut National de la Santé et de la Recherche Médicale
发明人:
申请号：
EP16198909.0
公开号：
EP3153526A1
申请日:
2009.01.30
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The invention relates to antibodies against human CD39 and use thereof for inhibiting T regulatory cells (Treg) activity. More particularly CD39 antibodies may be used for the treatment or prevention of cancers and infectious diseases.
